Search NASA⌕ Search

SEARCH · Search NASA

Results for “Emission Tomography”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 181 records · Page 10
All sourcesNASA NTRSDOE OSTI
NASA NTRS2008

Fabricating High-Resolution X-Ray Collimators

A process and method for fabricating multi-grid, high-resolution rotating modulation collimators for arcsecond and sub-arcsecond x-ray and gamma-ray imaging involves photochemical machining and precision stack lamination. The special fixturing and etching techniques that have been developed are used for the fabrication of multiple high-resolution grids on a single array substrate. This technology has application in solar and astrophysics and in a number of medical imaging applications including mammography, computed tomography (CT), single photon emission computed tomography (SPECT), and gamma cameras used in nuclear medicine. This collimator improvement can also be used in non-destructive testing, hydrodynamic weapons testing, and microbeam radiation therapy.

Appleby, Michael↗
DOE OSTI2022

Evaluation of 134 Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225 Ac

The in vivo generator 134 Ce/ 134 La has the potential to serve as a PET imaging surrogate for both alpha-emitting 225 Ac and 227 Th radionuclides due to the unique Ce III /Ce IV redox couple and the relatively long half-life of 134 Ce. Furthermore, the purpose of this study was to demonstrate the compatibility of 134 Ce with DOTA-based antibody drug conjugates, which would act as therapeutic agents when incorporating 225 Ac.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Comorbid conditions in individuals assessed by SPECT: Study of a reference cardiology center in Mexico City

Background: There is an increasing prevalence of comorbidities in patients with ischemic heart disease (IHD) in developing countries. The aim of this work is to assess the prevalence of comorbidities and associated factors for IHD among patients at a reference cardiology center. Design and Methods: This was a cross-sectional study. A complete clinical history which focused on the main comorbidities, previous myocardial infarction, and the main reason of referral was assessed. A single-photon emission computed tomography (SPECT) myocardial perfusion study (MPS) with two protocols was performed. Results: We included 1998 patients, 64.2% male, median age 63 (I.R.: 56–71) years. 1514 (75.8%) subjects had at least one associated comorbidity. The main comorbidity was diabetes (T2D) (772: 38.6%), followed by systemic hypertension (737: 36.9%), smoking (518: 25.9%), and dyslipidemia (517: 25.9%). 806 (40.3%) had histories of previous myocardial infarctions. The main cause of referral was angina (923: 46.2%). We identified 1330 (66.5%) abnormal MPS. 460 (23%) had ischemia, 292 (14.6%) infarction, and 578 (28.9%) ischemia and infarction. Conclusion: An increased prevalence of comorbidities was found in patients who were studied in the Nuclear Cardiology Department (NCD): most of them had traditional risk factors attributable to myocardial infarction. A great percentage were newly diagnosed with both ischemia and infarction.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2020

Gamma Spectrometry Examination of the AGR-3/4 Irradiation

The results from gamma spectrometry examination of the different components from the combined third and fourth U.S. Advanced Gas Reactor (AGR) TRISO-coated particle fuel irradiation tests (AGR-3/4) have been analyzed. This experiment was designed to provide information about in-pile fission product migration. In each of the 12 capsules, a single stack of four compacts with designed-to-fail (DTF) particles surrounded by inner and outer graphite and/or graphitic matrix rings and a graphite sink ring were irradiated in the Advanced Test Reactor (ATR) at Idaho National Laboratory (INL). Gamma spectrometry has been used to evaluate the gamma-emitting fission product inventory of compacts from the irradiation and evaluate the burnup of these compacts based on the activity of the radioactive cesium isotopes (i.e., Cs-134 and Cs-137) in the compacts. Burnup from gamma spectrometry compares well with predicted burnup from simulations. The inner and outer rings were also examined by gamma spectrometry to evaluate the total fission product inventory of the rings, and gamma emission computed tomography (GECT) was used to investigate the spatial distribution of gamma-emitting fission products within the rings. This report focuses on results obtained via the Precision Gamma Scanner (PGS) for the compacts and inner and outer rings. These non-destructive gamma measurements are currently being compared to recent destructive measurements of spatial fission product distributions in the rings and to predictions made via mathematical modeling. A separate report discusses the entire AGR-3/4 fission product mass balance for all irradiation capsule components including the inner and outer rings, graphite sink rings, capsule spacers, capsule foils, through tubes, and felts. This report is similar to the conference proceedings: Harp, J.M., Demkowicz, P.A., and Stempien, J.D., “Initial gamma spectrometry examination of the AGR-3/4 irradiation,” International Topical Meeting High Temperature Reactor Technology (HTR 2016), Las Vegas, NV, USA, November 2016, Paper HTR2016-18593, but it has been updated to reflect all the data that has been collected on AGR-3/4 using PGS. The Appendices contain extensive data from the collected gamma spectra.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗
DOE OSTI2021

Gamma Spectrometry Examination of the AGR-3/4 Irradiation

The results from gamma spectrometry examination of the different components from the combined third and fourth U.S. Advanced Gas Reactor (AGR) TRISO-coated particle fuel irradiation tests (AGR-3/4) have been analyzed. This experiment was designed to provide information about in-pile fission product migration. In each of the 12 capsules, a single stack of four compacts with designed-to-fail (DTF) particles surrounded by inner and outer graphite and/or graphitic matrix rings and a graphite sink ring were irradiated in the Advanced Test Reactor (ATR) at Idaho National Laboratory (INL). Gamma spectrometry has been used to evaluate the gamma-emitting fission product inventory of compacts from the irradiation and evaluate the burnup of these compacts based on the activity of the radioactive cesium isotopes (i.e., Cs-134 and Cs-137) in the compacts. Burnup from gamma spectrometry compares well with predicted burnup from simulations. The inner and outer rings were also examined by gamma spectrometry to evaluate the total fission product inventory of the rings, and gamma emission computed tomography (GECT) was used to investigate the spatial distribution of gamma-emitting fission products within the rings. This report focuses on results obtained via the Precision Gamma Scanner (PGS) for the compacts and inner and outer rings. These non-destructive gamma measurements are currently being compared to recent destructive measurements of spatial fission product distributions in the rings and to predictions made via mathematical modeling. A separate report discusses the entire AGR-3/4 fission product mass balance for all irradiation capsule components including the inner and outer rings, graphite sink rings, capsule spacers, capsule foils, through tubes, and felts. This report is similar to the conference proceedings: Harp, J.M., Demkowicz, P.A., and Stempien, J.D., “Initial gamma spectrometry examination of the AGR-3/4 irradiation,” International Topical Meeting High Temperature Reactor Technology (HTR 2016), Las Vegas, NV, USA, November 2016, Paper HTR2016-18593, but it has been updated to reflect all the data that has been collected on AGR-3/4 using PGS. The Appendices contain extensive data from the collected gamma spectra.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗
DOE OSTI2019

Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis

Background: Technetium-based bone scintigraphy is rapidly becoming the most common non-invasive imaging tool in the diagnosis of Transthyretin cardiac amyloidosis (ATTR). Skeletal muscle uptake has been described with technetium-99m-3,3-diphosphono-1,2-propanodicarboxylic acid (TcDPD), and may account for masking of bony uptake. We sought to investigate skeletal muscle uptake of technetium-99m-pyrophosphate (TcPYP) in patients with ATTR. Methods and Results: This was a retrospective analysis of 57 patients diagnosed with ATTR who underwent TcPYP scintigraphy. Cardiac uptake was assessed on whole-body planar imaging using a semiquantitative scale (grades 0 to 3) and on single-photon emission computed tomography (SPECT) with CT attenuation correction using total myocardial counts per voxel after a 3-hour incubation. Skeletal muscle (psoas and biceps), vertebral body, LV myocardium, and blood pool mean counts were calculated. In the cohort (age 78 ± 9 years, 77% male, and 30% hereditary ATTR), there was no visualized tracer uptake in skeletal muscle or soft tissue on qualitative SPECT assessment. Total and blood pool-corrected uptake in the muscle groups were significantly less than myocardium and bone (P < 0.001). Blood pool-corrected muscle uptake was not associated with semiquantitative grade 3 vs 2 uptake (psoas P = 0.66, biceps P = 0.13) or presence of hereditary ATTR (psoas P = 0.43, biceps P = 0.69). As bony uptake decreased, there was no corresponding increase in skeletal muscle uptake. Conclusions: In patients with ATTR cardiac amyloidosis, skeletal muscle uptake of TcPYP is minimal when assessed by qualitative and quantitative metrics, and is not significantly different in patients with grade 2 vs 3 semiquantitative uptake. The properties of this tracer may be different than TcDPD with respect to non-cardiac uptake.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance

Background: Single-photon emission computed tomography has shown relevant limitations in the quantification of left ventricular (LV) mass. We sought to compare the estimates of LV mass on Cadmium-Zinc-Telluride (CZT) myocardial perfusion imaging (MPI) as compared to cardiac magnetic resonance (CMR). Methods and results: Twenty-five patients underwent MPI on a CZT camera and CMR on a 1.5 T scanner within 12 ± 3 weeks. LV mass was quantified on CZT images using two softwares: 4D-MSPECT (4DM) and Emory Cardiac Toolbox (ECTb). LV mass by CMR was quantified using MASS software (Medis, Leiden, The Netherlands). LV mass values obtained with 4DM and ECTb were highly reproducible [intraclass correlation coefficients .98 (95% CI .97-.99), and .98 (95% CI 0.97-.99), respectively]. The mean LVM mass values were 151 ± 44 g on CMR, 151 ± 43 g with 4DM (P = NS vs CMR), and 157 ± 42 g with ECTb (P < .001 vs CMR; P = .007 vs 4DM) CZT images. There was an excellent correlation between LV mass values between CMR and both 4DM (R{sup 2} = .95; P < .001) and ECTb (R{sup 2} = .98; P < .001) with narrow limits of agreement (− 13.6% to + 13.4% for 4DM, and − 5.6% to + 14.1% for ECTb). Conclusions: The evaluation of LV mass is feasible on CZT images, showing excellent agreement with CMR.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging

Background: Myocardial perfusion imaging (MPI) using single-photon emission computed tomography (SPECT) is useful in the evaluation of cardiac allograft vasculopathy (CAV) in heart transplant (HTx) recipients. The current study evaluated the long-term prognostic value of stress SPECT MPI for predicting all-cause mortality and cardiac events in HTx recipients. Methods: The study population consisted of 166 HTx recipients (mean age 54 ± 10 years, 84% male) who underwent exercise or dobutamine stress {sup 99m}Tc-tetrofosmin SPECT MPI for the assessment of CAV. An abnormal SPECT MPI was defined as the presence of a fixed or a reversible perfusion defect. Endpoints were all-cause mortality, cardiac mortality, and non-fatal myocardial infarction (MI). Results: MPI abnormalities were detected in 55 patients (33%), including fixed defects in 28 patients (17%), partially reversible in 17 patients (10%), and completely reversible defects in 10 patients (6%). During a median follow-up of 12.8 years (range 0-15, mean follow-up 9.5 years), 109 (66%) patients died (all-cause mortality), of which 67 (40%) were due to cardiac causes. A total of 5 (3%) patients experienced a non-fatal MI. HTx recipients with a normal stress {sup 99m}Tc-tetrofosmin SPECT MPI had a significantly better prognosis as compared with those with an abnormal study, up to 5 years after the initial test. The presence of a reversible perfusion defect was a significant predictor of all-cause mortality, cardiac mortality, and major cardiac events, during the entire follow-up period. Conclusions: Stress {sup 99m}Tc-tetrofosmin SPECT MPI provides valuable prognostic information for the prediction of long-term outcome in HTx recipients. Patients with a normal stress {sup 99m}Tc-tetrofosmin SPECT MPI have a significantly better prognosis as compared with those with an abnormal study, up to 5 years after initial testing.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data

Purpose: To determine whether the left ventricular ejection fractions (EFs), measured on a high-sensitivity CZT single photon emission computed tomography (SPECT)-camera with a 70% reduction in recording times and a prevention of EF overestimation through an additional count-calibration, are concordant with reference EF from planar radionuclide angiography (2D-RNA). Methods: An additional 10-minute CZT-SPECT recording was performed in patients referred to 2D-RNA for cardiomyopathy (n = 23) or chemotherapy monitoring (n = 50) with an in vivo red blood cell labeling with 850 MBq {sup 99m}TcO{sub 4}{sup −}. The EF, obtained from CZT-SPECT with 100% (SPECT100) or 30% (SPECT30) projection times and with a SPECT-count calibration on the 2D-RNA counts of corresponding cavity volumes, were compared to EF from 2D-RNA. Results: Strong and equivalent relationships were documented between the EF from 2D-RNA and the calibrated EF from SPECT100 (y = 0.89x + 6.62; R{sup 2} = 0.87) and SPECT30 (y = 0.87x + 8.40; R{sup 2} = 0.85), and the mean EF from SPECT100 (54% ± 15%) and SPECT30 (53% ± 16%) were close to that from 2D-RNA (55% ± 15%). However, upward shifts in these mean values were documented in the absence of count calibration for both SPECT100 (60% ± 18%) and SPECT30 (60% ± 18%). Conclusion: Left ventricular EF may be determined on a high-sensitivity CZT-camera, a 70% reduction in injected activities, and an additional count-calibration for further enhancing the concordance with 2D-RNA values. [French] French Abstract: Objectif: Déterminer si les fractions d'éjection ventriculaire gauche (EF) mesurées sur une caméra CZT SPECT à haute sensibilité avec une réduction de 70% des temps d'enregistrement et une prévention de la surestimation de l'EF grâce à un étalonnage supplémentaire des coups concordent avec les EF de référence obtenues par angiographie scintigraphique planaire (2D-RNA). Méthodes: Un enregistrement CZT-SPECT supplémentaire de 10 minutes a été réalisé chez les patients référés pour évaluation de cardiomyopathie (n=23) ou suivi de chimiothérapie (n = 50) par angiographie scintigraphique planaire (2D-RNA) au globules rouges marqués avec 850 MBq 99mTcO4-. Les EF, obtenues au moyen d’une caméra CZT-SPECT avec 100% (SPECT100) ou 30% (SPECT30) de temps d’acquisition et avec étalonnage des coups SPECT sur les images 2D-RNA des volumes de cavité correspondants ont été comparés aux EF à partir de 2D-RNA. Résultats: une corrélation significative existe entre les EF obtenues par 2D-RNA et les EF étalonnées obtenues par SPECT100 (y = 0,89x + 6,62; R2 = 0,87) et SPECT30 (y = 0,87x + 8,40; R2 = 0,85). Les EF moyennes de SPECT100 (54 ± 15%) et SPECT30 (53 ± 16%) sont similaires à celles obtenues par 2D-RNA (55 ± 15%). En l'absence d'étalonnage de comptage des études SPECT100 (60 ± 18%) et SPECT30 (60 ± 18%), ces valeurs moyennes d’EF sont généralement plus élevées. Conclusion: La fonction ventriculaire gauche peut être déterminée avec une caméra CZT à haute sensibilité, une réduction des activités injectées et un étalonnage supplémentaire des coups pour améliorer la concordance avec les valeurs obtenues par 2D-RNA. [Spanish] Spanish Abstract: Propósito: Determinar si la fracción de eyección del ventrículo izquierdo, medida con la cámara CZT-SPECT con una reducción del 70% en tiempo de grabación y con la prevención de la sobreestimación mediante una calibración de cuentas adicional, que sea concordante con el valor referencia de fracción de eyección mediante radiografía planar de radionucleidos. (2D-RNA). Métodos: Una grabación adicional de 10 minutos con CZT-SPECT se realizo en pacientes referidos a radiografía planar de radionucleidos (2D-RNA) por miocardiopatías. (n = 23) o para monitorizar las quimioterapias (n = 50) con marcaje de glóbulos rojos con 850 MBq 99m TcO4. La fracción de eyección obtenida por CZT-SPECT con 100% (SPECT100) o 30% (SPECT30) de tiempo de proyección, y con SPECT con calibración de cuentas con el 2D-RNA, los volúmenes de cavidades fueron comparados con fracción de eyección . Relaciones fuertes y equivalentes fueron documentados entre fracción de eyección del 2D-RNA, y la forma calibrada de la fracción de eyección SPECT100 (y = 0.89x + 6.62; R2 = 0.87) y SPECT30 y = 0.87x + 8.40; R2 = 0.85), y la media de fracción de eyección de SPECT100 (54 ± 15%) and SPECT30 (53 ± 16%) fueron cercanos a la de el 2D-RNA (55 ± 15%). Aunque, aumentos en estas medias se documentaron en la ausencia de la calibración de cuentas para SPECT100 (60 ± 18%) y SPECT30 (60 ± 18%). Conclusión: La fracción de eyección del ventrículo izquierdo puede ser determinada con una cámara CZT de alta sensibilidad, una reducción del 70% en actividades inyectadas y la calibración de cuentas adicional para realzar la concordancia con los valores de 2D-RNA. [Chinese] Chinese Abstract: 目的: 以平面放射性核素血管造影 (2D-RNA) 测定左心室射血分数 (EF) 作为参考标准,为确定利用高灵敏度 CZT SPECT 相机在减少 70% 的记录时间, 并结合计数校准防止高估情况下测量的 EF值, 是否与 2D-RNA 测得的 EF 值一致。 方法: 对心肌病 (n = 23) 或化疗监测 (n = 50) 的患者采用体内标记法注射 850 MBq {sup 99m}TcO{sub 4} 标记的红细胞进行 2D-RNA ,随后再采集 10 分钟 CZT-SPECT。 对 CZT-SPECT 100% 投影时间 (SPECT100) 或 30% 投影时间 (SPECT30) 获得的图像进行重建, 并进行计数校准 (对相应容积获得的 2D-RNA 计数通过 SPECT 校准)获得 EF 值, 与 2D-RNA 测定的 EF 的进行比较。 结果: 2D-RNA 测定的 EF 值与 SPECT100 校准后测定的 EF 值 (y = 0.89x + 6.62; R{sup 2} = 0.87) 及 SPECT30 (y = 0.87x + 8.40; R{sup 2} = 0.85) 校准后 EF 值具有高度相关性, 并且 SPECT100 (54 ± 15%) 和 SPECT30 (53 ± 16%) 测定的 EF 平均值与 2D-RNA 测定的 EF 平均值 (55 ± 15%) 非常接近。 但是, 在没有计数校准的情况下, SPECT100 (60 ± 18%) 和 SPECT30 (60 ± 18%) 测定的 EF 平均值会被高估。 结论: 高灵敏度 CZT 相机可在减少 70% 的注射剂量情况下测定左心室 EF 值, 结合计数校准可进一步提高与 2D-RNA测得的 EF 值的一致性。 关键词: 放射性核素血管造影; 血池 SPECT; CZT 相机; 左心室射血分数; 校准曲线。.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
NASA NTRS1991

A rocket tomography measurement of the N2(+) 3914 A emission rates within an auroral arc

A rocket tomography experiment designed to measure the two-dimensional distribution of the N2(+) 3914 A volume emission rates within an auroral arc is described. A simple filter photometer on board a sounding rocket, which was launched during the ARIES auroral campaign, was used to measure the 3914 A aruoral brightnesses at elevation angles ranging from 0 to 360 deg in the plane of the rocket trajectory. The measured auroral brightnesses have been tomographically inverted to recover the local 3914 A volume emissioin rates as a function of both altitude and latitude within the arc. The tomographic inversion procedure, which is based upon a maximum probability algebraic reconstruction approach, is described, and the implications of the results for studies of auroral excitation processes are briefly discussed.

Mcdade, I. C.↗
DOE OSTI2023

Coded aperture and Compton imaging for the development of 225 Ac‐based radiopharmaceuticals

Abstract Background Targeted alpha‐particle therapy (TAT) has great promise as a cancer treatment. Arguably the most promising TAT radionuclide that has been proposed is 225 Ac. The development of 225 Ac‐based radiopharmaceuticals has been hampered due to the lack of effective means to study the daughter redistribution of these agents in small animals at the preclinical stage. Purpose The ability to directly image the daughters, namely 221 Fr and 213 Bi, via their gamma‐ray emissions would be a boon for preclinical studies. That said, conventional medical imaging modalities, including single photon emission computed tomography (SPECT) based on nonmultiplexed collimation, cannot be employed due to sensitivity limitations. Methods As an alternative, we propose the use of both coded aperture and Compton imaging with the former modality suited to the 218‐keV gamma‐ray emission of 221 Fr and the latter suited to the 440‐keV gamma‐ray emission of 213 Bi. Results This work includes coded aperture images of 221 Fr and Compton images of 213 Bi in tumor‐bearing mice injected with 225 Ac‐based radiopharmaceuticals. Conclusions These results are the first demonstration of visualizing and quantifying the 225 Ac daughters in small animals through the application of coded aperture and Compton imaging.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2023

Simulation studies of a full-ring, CZT SPECT system for whole-body imaging of 99m Tc and 177 Lu

Single photon emission computed tomography (SPECT) is an imaging modality that has demonstrated its utility in a number of clinical indications. Despite this progress, a high sensitivity, high spatial resolution, multi-tracer SPECT with a large field of view suitable for whole-body imaging of a broad range of radiotracers for theranostics is not available. With the goal of filling this technological gap, we have designed a cadmium zinc telluride (CZT) full-ring SPECT scanner instrumented with a broad-energy tungsten collimator. The final purpose is to provide a multi-tracer solution for brain and whole-body imaging. Our static SPECT does not rely on the dual- and the triple-head rotational SPECT standard paradigm, enabling a larger effective area in each scan to increase the sensitivity. We provide a demonstration of the performance of our design using a realistic model of our detector with simulated body-sized phantoms filled with 99m Tc and 177 Lu. Our SPECT design can resolve 7.9 mm rods for 99m Tc (140 keV) and 9.5 mm for 177 Lu (208 keV) in a hot-rod Derenzo phantom with a 3-min exposure and reach an image contrast of 78% for 99m Tc and 57% for 177 Lu using the NEMA IQ phantom with a 6-min exposure. Our modified scatter correction shows an improved contrast-recovery ratio compared to a standard correction. In this paper, we demonstrate the good performance of our design for whole-body imaging purposes. This adds to our previous demonstration of improved qualitative and quantitative 99m Tc imaging of brain perfusion and 123 I imaging of dopamine transport with respect to state-of-the-art NaI dual-head cameras. We show that our design provides similar IQ and contrast to the commercial full-ring SPECT VERITON for 99m Tc. Regarding 177 Lu imaging of the 208 keV emissions, our design provides similar contrast to that of other state-of-the-art SPECTs with a significant reduction in exposure. In conclusion, the high sensitivity and extended energy range up to 250 keV makes our SPECT design a promising alternative for clinical imaging and theranostics of emerging radionuclides.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗
DOE OSTI2021

Evaluation of a Variable-Aperture Full-Ring SPECT System using Large-Area Pixelated CZT Modules: A Simulation Study for Brain SPECT Applications

Single photon emission computed tomography (SPECT) scanner using cadmium zinc telluride (CZT) offers improved imaging capability over conventional NaI (Tl)-based SPECT scanner. We aim to demonstrate a full-ring SPECT system design with eight large-area CZT detectors that can be used for a broad spectrum of SPECT radiopharmaceuticals and provides higher sensitivity and better spatial resolution than those of conventional NaI (Tl)-based gamma cameras. A newly-designed full-ring SPECT system is composed of 8 large-area CZT cameras (128 mm × 179.2 mm effective area) that can be independently swiveled around their own axes of rotation independently and can have radial motion for varying aperture sizes that can be adapted to different sizes of imaging volume. Extended projection data were generated by conjoining projections of two adjacent detectors to overcome the limited field-of-view (FOV) by each CZT camera. Using Monte Carlo simulations, we evaluated this new system design with digital phantoms including a Derenzo hot-rod phantom and a Zubal brain phantom. Comparison of performance metrics such as spatial resolution, sensitivity, contrast-to-noise ratio (CNR), and contrast-recovery ratio were made between our design and a conventional SPECT scanner. The proposed scanner could result in up to about 3 times faster in acquisition time over conventional scan time at same acquisition time per step. The spatial resolution of our proposed scanner was similar or better to that of the conventional scanner, and there was significant performance improvement over the conventional scanner particularly in sensitivity (approximately 4 times). Overall, we successfully reconstructed the phantom image for both 99 mTc-based perfusion and 123 I-based dopamine transporter (DaT) brain studies simulated for our new design. In particular, the striatal/background contrast-recovery ratio in 3-to-1 reference ratio was over the 0.8 for the 123 I-based DaT study. In conclusion, we demonstrated the potential of our new full-ring CZT SPECT design, showing improved performance metrics such as improved system sensitivity and CNR while maintaining other important imaging parameters such as spatial resolution.

36 MATERIALS SCIENCE↗
DOE OSTI2019

{sup 68}Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement

Purpose: To determine the diagnostic sensitivity and interobserver agreement of Gallium 68-prostate-specific membrane antigen positron emission tomography/computed tomography ({sup 68}Ga-PSMA-11 PET/CT) imaging for diagnosis and staging of patients with newly diagnosed prostate cancer (PC). Materials and methods: One hundred and seventy-three men (mean age, 68 ± 7.7 years; range 46–84 years) with newly diagnosed, untreated PC were enrolled in this prospective study between January 2017 and August 2018. All patients underwent a {sup 68}Ga-PSMA-11 PET/CT examination. For each patient, we determined the disease stage, the Gleason score, and the maximum standardized uptake value (SUVmax) for primary prostatic tumor and extraprostatic metastases. The diagnostic sensitivity and interobserver agreement of {sup 68}Ga-PSMA-11 PET/CT for diagnosis and staging of PC were established by histopathology as the reference standard. Results: {sup 68}Ga-PSMA-11 PET/CT examinations were interpreted as positive for PC in 166 of 173 patients (101 patients had primary prostatic tumor only, two patients had extraprostatic metastases only and 63 patients had combined lesions). The sensitivity of {sup 68}Ga-PSMA-11 PET/CT examination in the diagnosis of PC was 96%. {sup 68}Ga-PSMA-11 PET/CT produced a significant change of stage in 28.6% patients with an upstage in 17.9% patients and a downstage in 10.7% patients. The interobserver agreements were almost good to perfect (k = 0.63–0.89) for visual image interpretation, SUVmax measurement, and tumor staging. Conclusion: {sup 68}Ga-PSMA-11 PET/CT is a valuable tool with high diagnostic sensitivity (96%) and high reproducibility for diagnosis and staging of patients with newly diagnosed PC.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?

Purpose of Review: Diagnosis of myocarditis is challenging given its variable clinical manifestations and non-specific laboratory findings. Cardiac magnetic resonance (MR) is currently the preferred imaging modality for the diagnosis of myocarditis. {sup 18}F-fluoro-deoxy-glucose (FDG) positron emission tomography/computed tomography (PET/CT), as a functional imaging tool, has a potential role in the assessment of myocarditis by detecting the underlying myocardial inflammatory activity. Data are accumulating that simultaneous cardiac PET/MR may have complementary and incremental values for the evaluation of myocarditis compared to PET/CT or cardiac MR alone. The article aims to summarize the findings in the literature and discuss future directions of cardiac PET/MR for myocarditis. Recent Findings: The Lake Louis Criteria (CLL) of cardiac MR is widely used for the diagnosis of myocarditis. It has an overall acceptable sensitivity of 67% and specificity of 91% for acute myocarditis but does not have the same accuracy for chronic myocarditis. FDG PET/CT is capable of assessing myocarditis by providing metabolic information of inflammation as increased myocardial FDG uptake. In addition to reduced radiation exposure, FDG PET performed on a hybrid PET/MR may detect more myocarditis than FDG PET/CT, because of the delayed PET acquisition time on PET/MR. Case-based observations and small clinical studies of FDG PET/MR have shown that FDG PET findings as abnormally increased myocardial uptake correlate well with the cardiac MR biomarkers. FDG PET findings may add complementary and incremental values to cardiac MR by improving the sensitivity of cardiac MR for mild or borderline myocarditis, and increasing specificity for chronic myocarditis. Summary: Preliminary data from retrospective and case-based observational studies have suggested the complementary and incremental values of simultaneous cardiac FDG PET/MR for evaluation of myocarditis, compared to PET/CT or MR alone. Well-designed studies are needed to confirm the findings and to assess the value of cardiac PET/MR for clinical management and more importantly patient’s outcome in both acute and chronic myocarditis.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

Clinical Utility of [{sup 18}F]FDG-PET /CT in Pericardial Disease

Identification of the etiology of pericardial disease is challenging because the accessibility to pericardial fluid and tissue is limited and there is a relatively low yield of fluid and tissue analysis. Pericardial disease is associated with various systemic diseases and is frequently a first manifestation of other systemic diseases. Detecting the cause of pericarditis and minimizing the subsequent inflammatory process can possibly prevent long-term complications. Purpose of Review: To review the clinical utility of [{sup 18}F]-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography ([{sup 18}F]FDG-PET/CT) in the diagnosis and treatment of pericardial disease. Recent Findings: [{sup 18}F]FDG-PET/CT can visualize the hypermetabolic tissues of both malignancy and inflammation. Distribution of [{sup 18}F]FDG-PET/CT uptake can provide information for neoplastic disease. If malignancy is ruled out, high uptake of pericardium is associated with active inflammation of the pericardium, and thus response to anti-inflammatory agents can also be predicted with [{sup 18}F]FDG-PET/CT imaging. Summary: [{sup 18}F]FDG-PET/CT can be helpful for diagnosing and establishing prognosis and for planning for anti-inflammatory treatment in pericardial disease.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2019

{sup 18}F-FDG PET/CT-imaging of left ventricular assist device infection: a retrospective quantitative intrapatient analysis

Background: Despite the use of {sup 18}F-fluorodeoxyglucose ({sup 18}F-FDG) positron emission tomography/computed tomography (PET/CT), diagnosis of a driveline infection in ventricular assist device (LVAD) recipients remains challenging. Our aim was to evaluate the potential of a baseline {sup 18}F-FDG PET/CT (prior to an infection) for the diagnosis of an LVAD-related infection. Methods: We retrospectively selected all LVAD recipients who had undergone two consecutive whole-body {sup 18}F-FDG PET/CT examinations between January 2010 and December 2016. PET/CT was analyzed qualitatively (uptake pattern) and semi-quantitatively (SUV{sub max} and ∆SUV{sub max}). SUV{sub max} was measured and compared in five distinctive volumes of interest along the LVAD driveline. An SUV{sub max} threshold was calculated. Final diagnosis was made by clinical examination, microbiological parameters, and molecular imaging. Results: Thirty patients were enrolled (mean age 54 ± 12 years; 26 male). Mean difference in SUV{sub max} for all five positions between the first and the second PET/CT along the driveline was significantly higher in patients with an LVAD-related infection (mean ∆SUV{sub max} = 4.38 ± 1.44) compared to those without a driveline infection (mean ∆SUV{sub max} = 0.03 ± 0.43), P < 0.05. Applying ROC analysis, an SUV{sub max} threshold of 3.88 resulted in a sensitivity and specificity of 100%, respectively. There were three distinctive uptake patterns in patients with a driveline infection. Conclusion: PET/CT diagnosis in the context of an LVAD-related infection can be improved by comparison to a baseline examination using a distinctive SUV{sub max} threshold.

62 RADIOLOGY AND NUCLEAR MEDICINE↗